Unlocking the Potential of ADAM29 as a Drug Target and Biomarker

Target Name: ADAM29

NCBI ID: G11086

ADAM29

Unlocking the Potential of ADAM29 as a Drug Target and Biomarker

Introduction

ADAM29 (A disintegrin and metalloproteinase domain 29) is a protein that plays a crucial role in various cellular processes, including cell adhesion, migration, and invasion. It is a member of the ADAM family, which includes several structurally similar proteins that have been implicated in various diseases, including cancer, Alzheimer's, and Parkinson's. In this article, we will explore the potential of ADAM29 as a drug target and biomarker.

The ADAM29 Protein

ADAM29 is a 29-kDa protein that is expressed in various tissues and cells, including liver, lung, heart, kidney, and brain. It is composed of a 154 amino acid long N-terminal region, a 134 amino acid long N-terminal region, and a 16 amino acid long C-terminus. The N-terminal region is rich in conserved domains, including a disintegrin domain and a metalloproteinase domain.

The disintegrin domain is a conserved region that is involved in the formation of disulfide bonds, which is important for protein stability and function. The metalloproteinase domain is a catalytic domain that is involved in the hydrolysis of metal ions, such as iron ions, which is essential for various cellular processes, including cell signaling, metabolism, and inflammation.

Functional domain analysis

The functional domain analysis of ADAM29 is as follows:

1. Cell adhesion and migration: ADAM29 is a key protein for cell adhesion and migration. Studies have shown that the N-terminus of ADAM29 is rich in a domain called a hydrophobic fragment that can bind to the extracellular matrix, thereby promoting cell adhesion and migration. In addition, the C-terminus of ADAM29 also contains a domain called a recruitment domain, which can recruit other proteins to interact with it and thereby participate in cell migration.

2. Cell signaling: ADAM29 plays an important role in cell signaling. Studies have shown that the N-terminal domain of ADAM29 can bind to the extracellular matrix, thereby preventing the binding of signaling molecules and thus inhibiting cell signaling. In addition, the C-terminal domain of ADAM29 can interact with a variety of proteins and thereby participate in the regulation of intracellular signaling.

3. Cell invasion and tumorigenesis: ADAM29 also plays an important role in cell invasion and tumorigenesis. Studies have shown that the N-terminal domain of ADAM29 can bind to the extracellular matrix, thereby promoting cell invasion and tumorigenesis. In addition, the C-terminal domain of ADAM29 can participate in the formation of intracellular new blood vessels, thereby providing nutrients and oxygen to tumors.

4. Neuronal function: ADAM29 also plays an important role in neuronal function. Studies have shown that the N-terminal domain of ADAM29 can bind to receptors on neuronal cell membranes, thereby participating in neuronal signaling. In addition, the C-terminal domain of ADAM29 can participate in the formation of neuronal synapses, thereby affecting neuronal function.

drug target

ADAM29 has high potential as a drug target. Since ADAM29 plays an important role in many biological processes, drug development targeting ADAM29 has broad application prospects.

1. Anti-tumor drugs: Since ADAM29 plays an important role in tumorigenesis, anti-tumor drugs can be developed targeting ADAM29. For example, the use of ADAM29 antagonists can inhibit the adhesion and migration of tumor cells, thereby improving the immune evasion ability of tumors.

2. Neuron protective drugs: Since ADAM29 plays an important role in neuron function, neuron protective drugs can be developed targeting ADAM29. For example, using drugs that interfere with ADAM29 function could

Protein Name: ADAM Metallopeptidase Domain 29

Functions: May be involved in spermatogenesis and fertilization. Seems to be a non catalytic metalloprotease-like protein

The "ADAM29 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADAM29 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets